Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGDS | O60760 | 1/20 | 1.00 |
| ▸ | CHAT | P28329 | 4/20 | 0.85 |
| ▸ | USP2 | O75604 | 2/20 | 0.85 |
| ▸ | APEX1 | P27695 | 2/20 | 0.85 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.82 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.82 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.77 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.77 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.77 |
| ▸ | FUT8 | Q9BYC5 | 2/20 | 0.77 |
| ▸ | P2RY12 | Q9H244 | 5/20 | 0.71 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | GAA | P10253 | 1/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cibacron Blue SCHEMBL30286286 | 1.00 | HPGDS (1.00) | HPGDSCHATUSP2APEX1ENPP3 | |
| Cibacron Blue SCHEMBL29373073 | 1.00 | HPGDS (1.00) | HPGDSCHATUSP2APEX1ENPP3 | |
| Cibacron Blue SCHEMBL29558558 | 1.00 | HPGDS (1.00) | HPGDSCHATUSP2APEX1ENPP3 | |
| SCHEMBL17000442 | 0.97 | HPGDS (0.95) | HPGDSCHATUSP2APEX1ENPP3 | |
| SCHEMBL13213990 | 0.95 | HPGDS (0.91) | HPGDSCHATUSP2APEX1ENPP3 | |
| SCHEMBL13046386 | 0.94 | CHAT (0.90) | HPGDSCHATUSP2APEX1ENPP3 | |
| SCHEMBL12662265 | 0.93 | HPGDS (0.86) | HPGDSCHATUSP2APEX1ENPP3 | |
| SCHEMBL11885371 | 0.93 | HPGDS (0.86) | HPGDSCHATUSP2APEX1ENPP3 | |
| SCHEMBL19524846 | 0.93 | HPGDS (0.86) | HPGDSCHATUSP2APEX1ENPP3 | |
| SCHEMBL13856914 | 0.92 | CHAT (1.00) | HPGDSCHATUSP2APEX1ENPP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3613486-B1 | METHOD AND INSTALLATION FOR THE PURIFICATION OF EPO AND/OR AN EPO DERIVATIVE | UGA BIOPHARMA GMBH (DE) | 2020-10-07 | — | — | EP | claimed |
| EP-3613486-A1 | METHOD AND INSTALLATION FOR THE PURIFICATION OF EPO AND/OR AN EPO DERIVATIVE | UGA Biopharma GmbH (DE) | 2020-02-26 | — | — | EP | claimed |
| US-9096683-B2 | Method for purifying recombinant FSH | RATIOPHARM GMBH (DE) | 2015-08-04 | — | — | US | claimed |
| US-20250332292-A1 | IN VIVO CROSSLINKABLE HYDROGELS WITH COVALENTLY ATTACHED DYE FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-10-30 | — | — | US | disclosed |
| US-20250128238-A1 | SEPARATION MEDIA CONTAINING DYES | DONALDSON COMPANY, INC. | 2025-04-24 | — | — | US | disclosed |
| CN-116332157-B | Preparation method of nitrogen-metal doped carbon material and application of nitrogen-metal doped carbon material in rubber | 河北省科学院能源研究所 | 2023-08-15 | — | — | CN | disclosed |
| CN-116332157-A | Preparation method of nitrogen-metal doped carbon material and application of nitrogen-metal doped carbon material in rubber | 河北省科学院能源研究所 | 2023-06-27 | — | — | CN | disclosed |
| US-20230193339-A1 | Preparation and Purification of Hypersialylated IGG | MOMENTA PHARMACEUTICALS, INC. (US) | 2023-06-22 | — | — | US | disclosed |
| EP-4153617-A1 | PREPARATION AND PURIFICATION OF HYPERSIALYLATED IGG | Momenta Pharmaceuticals, Inc. (US) | 2023-03-29 | — | — | EP | disclosed |
| WO-2021236769-A1 | PREPARATION AND PURIFICATION OF HYPERSIALYLATED IGG | MOMENTA PHARMACEUTICALS, INC. (US) | 2021-11-25 | — | — | WO | disclosed |
| CN-113528423-A | Method for separating plasma lipoprotein and exosome | 温州医科大学附属眼视光医院 | 2021-10-22 | — | — | CN | disclosed |
| WO-2015164299-A1 | ORGANIC COLORANT COMPLEXES FROM REACTIVE DYES AND ARTICLES CONTAINING THE SAME | MILLIKEN & COMPANY (US) | 2015-10-29 | — | — | WO | disclosed |
| US-20150299468-A1 | Organic Colorant Complexes from Reactive Dyes and Articles Containing the Same | MILLIKEN & COMPANY (US) | 2015-10-22 | — | — | US | disclosed |
| US-9096683-B2 | Method for purifying recombinant FSH | RATIOPHARM GMBH (DE) | 2015-08-04 | — | — | US | disclosed |
| US-20090263784-A1 | THREE-DIMENSIONAL STRUCTURE OF PROSTAGLANDIN D SYNTHASE AND UTILIZATION THEREOF | URADE YOSHIHIRO | 2009-10-22 | — | — | US | disclosed |
| US-7547532-B2 | Three-dimensional structure of prostaglandin D synthase and utilization thereof | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2009-06-16 | — | — | US | disclosed |
| EP-1603543-A4 | THERAPEUTIC COMPOSITIONS | FLOREY HOWARD INST (AU) | 2009-03-04 | — | — | EP | disclosed |
| US-20070037883-A1 | Therapeutic compositions | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY & MEDICINE (AU) | 2007-02-15 | — | — | US | disclosed |
| EP-1603543-A1 | THERAPEUTIC COMPOSITIONS | Howard Florey Institute of Experimental Physiology and Medicine (AU) | 2005-12-14 | — | — | EP | disclosed |
| WO-2004075884-A1 | THERAPEUTIC COMPOSITIONS | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 2004-09-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250332292-A1 | IN VIVO CROSSLINKABLE HYDROGELS WITH COVALENTLY ATTACHED DYE FOR MEDICAL APPLICATIONS | CD44, CRYAA, ILK | HPGDS 120/4885CHAT 1055/4885USP2 381/4885 |
| US-20230193339-A1 | Preparation and Purification of Hypersialylated IGG | FCGR2A, FCGR1A, FCGR3B | HPGDS 942/4885CHAT 845/4885USP2 335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.